These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 35831908)
1. SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma. Chien CH; Yang WB; Chuang JY; Lee JS; Liao WA; Huang CY; Chen PY; Wu AC; Yang ST; Lai CC; Chi PI; Chu JM; Cheng SM; Liu CC; Hwang DY; Chen SH; Chang KY J Exp Clin Cancer Res; 2022 Jul; 41(1):220. PubMed ID: 35831908 [TBL] [Abstract][Full Text] [Related]
2. Role of SH3GLB1 in the regulation of CD133 expression in GBM cells. Chien CH; Lai CC; Chuang JY; Chu JM; Liu CC; Chang KY BMC Cancer; 2023 Jul; 23(1):713. PubMed ID: 37525108 [TBL] [Abstract][Full Text] [Related]
3. TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma. Yu J; Gao G; Wei X; Wang Y BMC Cancer; 2022 Jul; 22(1):786. PubMed ID: 35850753 [TBL] [Abstract][Full Text] [Related]
4. Lnc-TALC promotes O Wu P; Cai J; Chen Q; Han B; Meng X; Li Y; Li Z; Wang R; Lin L; Duan C; Kang C; Jiang C Nat Commun; 2019 May; 10(1):2045. PubMed ID: 31053733 [TBL] [Abstract][Full Text] [Related]
5. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme. Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406 [TBL] [Abstract][Full Text] [Related]
6. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization. Li Z; Fu WJ; Chen XQ; Wang S; Deng RS; Tang XP; Yang KD; Niu Q; Zhou H; Li QR; Lin Y; Liang M; Li SS; Ping YF; Liu XD; Bian XW; Yao XH J Exp Clin Cancer Res; 2022 Feb; 41(1):74. PubMed ID: 35193644 [TBL] [Abstract][Full Text] [Related]
7. Autophagy in combination therapy of temozolomide and IFN-γ in C6-induced glioblastoma: role of non-coding RNAs. Bashiri H; Moazam-Jazi M; Karimzadeh MR; Jafarinejad-Farsangi S; Moslemizadeh A; Lotfian M; Karam ZM; Kheirandish R; Farazi MM Immunotherapy; 2023 Oct; 15(14):1157-1169. PubMed ID: 37584216 [TBL] [Abstract][Full Text] [Related]
8. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition. Liu T; Li A; Xu Y; Xin Y Oncol Rep; 2019 Mar; 41(3):1883-1892. PubMed ID: 30664175 [TBL] [Abstract][Full Text] [Related]
9. A Key Role of DNA Damage-Inducible Transcript 4 (DDIT4) Connects Autophagy and GLUT3-Mediated Stemness To Desensitize Temozolomide Efficacy in Glioblastomas. Ho KH; Chen PH; Chou CM; Shih CM; Lee YT; Cheng CH; Chen KC Neurotherapeutics; 2020 Jul; 17(3):1212-1227. PubMed ID: 31916238 [TBL] [Abstract][Full Text] [Related]
10. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma. Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952 [TBL] [Abstract][Full Text] [Related]
11. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway. Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149 [TBL] [Abstract][Full Text] [Related]
12. Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells. Zampieri LX; Sboarina M; Cacace A; Grasso D; Thabault L; Hamelin L; Vazeille T; Dumon E; Rossignol R; Frédérick R; Sonveaux E; Lefranc F; Sonveaux P Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769368 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl-1 degradation. Liang H; Chen Z; Sun L Mol Carcinog; 2019 Aug; 58(8):1502-1511. PubMed ID: 31045274 [TBL] [Abstract][Full Text] [Related]
14. Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets. Chien CH; Chuang JY; Yang ST; Yang WB; Chen PY; Hsu TI; Huang CY; Lo WL; Yang KY; Liu MS; Chu JM; Chung PH; Liu JJ; Chou SW; Chen SH; Chang KY J Biomed Sci; 2019 Oct; 26(1):77. PubMed ID: 31629402 [TBL] [Abstract][Full Text] [Related]
15. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma. Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863 [TBL] [Abstract][Full Text] [Related]
16. FOXM1-mediated NUF2 expression confers temozolomide resistance to human glioma cells by regulating autophagy via the PI3K/AKT/mTOR signaling pathway. Guo L; Wu Z Neuropathology; 2022 Oct; 42(5):430-446. PubMed ID: 35701983 [TBL] [Abstract][Full Text] [Related]
17. Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy. Wang N; Huang R; Yang K; He Y; Gao Y; Dong D J Cell Mol Med; 2022 Feb; 26(3):893-912. PubMed ID: 34964241 [TBL] [Abstract][Full Text] [Related]
18. Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention. Yue Q; Wang Z; Shen Y; Lan Y; Zhong X; Luo X; Yang T; Zhang M; Zuo B; Zeng T; Lu J; Wang Y; Liu B; Guo H Adv Sci (Weinh); 2024 May; 11(19):e2309290. PubMed ID: 38477507 [TBL] [Abstract][Full Text] [Related]
19. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732 [TBL] [Abstract][Full Text] [Related]
20. Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide. Johannessen TC; Hasan-Olive MM; Zhu H; Denisova O; Grudic A; Latif MA; Saed H; Varughese JK; Røsland GV; Yang N; Sundstrøm T; Nordal A; Tronstad KJ; Wang J; Lund-Johansen M; Simonsen A; Janji B; Westermarck J; Bjerkvig R; Prestegarden L Int J Cancer; 2019 Apr; 144(7):1735-1745. PubMed ID: 30289977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]